# The Prevelance of Pulmonary Manifestation in Patients With Inflammatory Bowel Disease

> **NCT04613466** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- The Prevelance and Complications of Pulmonary Manifestations in Patients With Inflammatory Bowel Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04613466
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2022-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04613466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04613466, "The Prevelance of Pulmonary Manifestation in Patients With Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04613466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*